| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.66 ▼ -1.06% | Yesterday | $3.72 ▲ +0.45% | Tomorrow's Iovance Biotherapeutics Inc. Common Stock (IOVA) setup is anchored to $3.70 and targets $3.66 (-1.06%). The near-term read is downside; watch $3.81 / $3.59 because daily realized volatility is about 5.47%. |
Tomorrow's Iovance Biotherapeutics Inc. Common Stock (IOVA) setup is anchored to $3.70 and targets $3.66 (-1.06%). The near-term read is downside; watch $3.81 / $3.59 because daily realized volatility is about 5.47%. | ||||
| Week | $3.58 ▼ -3.30% | Last Week | $3.75 ▲ +1.39% | The 7-day Iovance Biotherapeutics Inc. Common Stock model moves from $3.75 to $3.58 (-3.30%). It gives downside momentum context for this stock, so breaks around $3.81 / $3.59 matter more than a single tick. |
The 7-day Iovance Biotherapeutics Inc. Common Stock model moves from $3.75 to $3.58 (-3.30%). It gives downside momentum context for this stock, so breaks around $3.81 / $3.59 matter more than a single tick. | ||||
| Month | $3.44 ▼ -7.03% | Last Month | $3.81 ▲ +2.95% | The 1-month Iovance Biotherapeutics Inc. Common Stock target is $3.44 (-7.03%), compared with the live reference near $3.70. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Iovance Biotherapeutics Inc. Common Stock target is $3.44 (-7.03%), compared with the live reference near $3.70. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.23 ▼ -12.62% | Last Year | $3.90 ▲ +5.30% | The 1-year Iovance Biotherapeutics Inc. Common Stock scenario points to $3.23 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Iovance Biotherapeutics Inc. Common Stock scenario points to $3.23 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $2.75 ▼ -25.71% | 5 Years Ago | $4.10 ▲ +10.80% | The 5-year Iovance Biotherapeutics Inc. Common Stock view is $2.75 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Iovance Biotherapeutics Inc. Common Stock view is $2.75 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $3.70 | Mid |
| Daily Change | -2.12% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $3.70 | Daily Change | -2.12% |
| Market Cap | $1.65B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.